Premium
Skin and Diet • 9 min min read

Oral Probiotics and Skin — The Gut-Skin Axis and What the Clinical Evidence Says

Do probiotic capsules improve your skin? The gut-skin axis, Lactobacillus rhamnosus GG for eczema, Saccharomyces boulardii, and oral vs. topical probiotics.

Published: 2025-12-10 • Updated: 2024-05-26

Your gut is home to more than 38 trillion bacteria — more than the number of cells in the human body. For decades, the gut and the skin were considered separate systems. Today we know they communicate with one another through a complex immune, hormonal, and metabolic network known as the gut-skin axis. So can probiotic capsules actually improve the condition of your skin?

The gut-skin axis — how the gut "talks" to the skin

The concept of the gut-skin axis is nothing new — back in 1930, dermatologists Stokes and Pillsbury proposed a link between emotional state, gut flora, and skin disease. Modern science has confirmed their intuition, although the mechanism has turned out to be far more complex.

Gut dysbiosis (an imbalance in the microbiota) can affect the skin through several pathways:

  • Immune: the gut contains 70–80% of the body's immune cells (GALT — gut-associated lymphoid tissue). Dysbiosis activates pro-inflammatory cytokines (IL-6, TNF-α, IL-17) that circulate in the bloodstream and can intensify skin inflammation.
  • Metabolic: gut bacteria produce short-chain fatty acids (SCFAs — butyrate, propionate, acetate) that regulate the inflammatory response. In dysbiosis, SCFA production falls.
  • Barrier: increased intestinal permeability ("leaky gut") can lead to the translocation of bacterial endotoxins (LPS) into the bloodstream, fuelling systemic inflammation.

This is why patients with inflammatory bowel disease (IBD) often suffer from co-occurring skin conditions — erythematous, psoriatic, and eczematous. This association is well documented in the gastroenterology literature.

Lactobacillus rhamnosus GG — the most thoroughly studied strain

Among the probiotics studied for their effect on the skin, Lactobacillus rhamnosus GG (LGG) has the strongest evidence — particularly in the context of atopic dermatitis (eczema) in infants.

A landmark study by Kalliomäki et al. (2001), published in The Lancet, showed that giving LGG to mothers in the final weeks of pregnancy and to infants during the first 6 months of life reduced the risk of developing eczema by 50% by the age of 2 (23% vs. 46% in the placebo group). The effect persisted at 4 years of follow-up (Kalliomäki et al., 2003).

However, subsequent replication studies produced mixed results:

  • Some confirmed the preventive effect (Rautava et al., 2012).
  • Others found no significant difference (Kopp et al., 2008).
  • A meta-analysis by Zuccotti et al. (2015) in the Journal of Allergy and Clinical Immunology estimated that probiotics (various strains) reduce the risk of eczema by roughly 20–25% — a moderate but statistically significant effect.

In its 2015 guidelines, the World Allergy Organization (WAO) conditionally recommends the use of probiotics in pregnant women, breastfeeding mothers, and infants from families with a history of atopy — though it stresses the low certainty of the evidence and the lack of consensus on the optimal strain and dose.

Saccharomyces boulardii — a probiotic yeast

Saccharomyces boulardii is a probiotic yeast best known for treating antibiotic-associated diarrhoea and Clostridioides difficile infections. Its potential effect on the skin is less studied than that of LGG, but there is some interesting data:

  • A pilot study by Chen et al. (2017) showed improvement in acne symptoms after 5 months of S. boulardii supplementation — but the sample was small.
  • S. boulardii has anti-inflammatory and immunomodulatory effects — it inhibits NF-κB activation and the production of pro-inflammatory cytokines.
  • As a yeast, it is not sensitive to antibiotics — it can be taken alongside antibiotic therapy.

The data are promising but clearly insufficient to form clinical recommendations.

Probiotics and acne — limited evidence

Acne vulgaris is an inflammatory disease in which Cutibacterium acnes (formerly Propionibacterium acnes) plays a key role. In theory, probiotics could modulate the inflammatory response — but the clinical evidence is still very early.

A systematic review by Araviiskaia et al. (2019) in the Journal of the European Academy of Dermatology and Venereology analysed the available studies and concluded that:

  • Several small studies suggest moderate improvement after supplementation with Lactobacillus and Bifidobacterium.
  • The mechanism likely involves reducing systemic inflammation and improving the gut barrier.
  • The quality of evidence is low — large placebo-controlled RCTs are needed.

At present, no probiotic strain is recommended by dermatology societies as a treatment for acne.

Oral vs. topical probiotics — a crucial distinction

More and more cosmetics market themselves as "probiotic" — but that is a completely different category from oral probiotics. The distinction is fundamental:

  • Oral probiotics work through the gut-skin axis — they modulate the gut microbiota, the GALT, and the systemic inflammatory response. The effects are indirect and delayed (weeks to months).
  • Topical probiotics (in cosmetics) — most often these are not live bacteria but bacterial lysates, postbiotics, or prebiotics. They act directly on the skin's microbiota and the epidermal barrier. The mechanism is different — competition with pathogens, bacteriocin production, and modulation of local pH.

You cannot assume that the benefits of one approach automatically carry over to the other. A serum with a Lactobacillus lysate is not the same thing as a capsule of live LGG.

Find out which cosmetics in the PurScore database contain probiotic ingredients — search for them on the ingredients page.

Practical tips

  • For eczema in infants with a family history of atopy — consider LGG in consultation with a paediatrician (WAO guidelines).
  • For acne — probiotics may help, but they won't replace dermatological treatment. Don't expect miraculous results.
  • For gut dysbiosis (after antibiotics, with IBS) — improving the gut microbiota may indirectly benefit the skin.
  • Choose strains with evidence — LGG, S. boulardii, and Bifidobacterium lactis BB-12 have the best data. A "10-strain complex" with no specifics is marketing.
  • Give it time — the effects of probiotics appear after at least 4–8 weeks of regular use.

If you're struggling with skin problems that may be linked to the gut (eczema, acne, psoriasis), consult a dermatologist and a gastroenterologist. Self-administered probiotic supplementation is no substitute for professional diagnosis. Check the ingredient lists of your cosmetics in the PurScore search tool.

FAQ

Yes, but the evidence is limited. The strongest data concern Lactobacillus rhamnosus GG for preventing eczema in infants. For acne and other skin conditions, the evidence is early and inconclusive.

It's a communication network between the gut and the skin, involving immune, metabolic, and barrier pathways. Gut dysbiosis can intensify skin inflammation through cytokines circulating in the bloodstream.

Oral probiotics modulate the gut microbiota and act indirectly through the gut-skin axis. Probiotics in cosmetics (most often lysates or postbiotics) act directly on the skin's microbiota. These are different mechanisms.

Lactobacillus rhamnosus GG has the strongest evidence (eczema prevention). Saccharomyces boulardii and Bifidobacterium lactis BB-12 also have data. Avoid products with vague "complexes" that don't specify the strains.

Want more articles like this?

Subscribe to our newsletter — free cosmetic ingredient tips, weekly.

Date protected per privacy policy.

Check products

Looking for cosmetics related to this topic? Compare ingredients and prices on PurScore.

0 products